All screening programmes do harm; some also do good. The responsibility of
the policy-maker is to decide which programmes do more good than harm at re
asonable cost and then introduce them, once they are confident that the scr
eening programme could and will reach the standard of quality required for
success. The ratio of benefit to harm is not, however, constant and this re
lationship demonstrates a shifting balance.